VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
JBS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
JBSJbs N.V.
$11.67$25.9B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksJBSFinancials

Jbs N.V. (JBS) Income Statement

12Y historyFree accessUpdated daily

Revenue growth decelerated sharply from 28.0% in 2025Q1 to -79.9% in 2026Q2, with gross margin falling to 10.8% and operating margin contracting to 2.5%, resulting in a net loss of $102.1M.

Income StatementBalance SheetCash FlowRatios

JBS Income Statement

Annual statement

JBS Income Statement

Jbs N.V. (JBS) annual income statement — 12-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14
Sales/Revenue382.19B471.14B416.95B363.82B383.97B362.5B270.2B204.52B181.68B163.17B170.38B162.91B120.47B
Revenue Growth %-16.97%13%14.61%-5.25%5.92%34.16%32.11%12.57%11.34%-4.23%4.58%35.23%-
Cost of Goods Sold336.87B410.82B354.18B324.17B322.93B294.01B224.99B172.58B155.34B139.4B149.07B140.32B101.8B
COGS % of Revenue-87.2%84.94%89.1%84.1%81.11%83.27%84.38%85.5%85.43%87.49%86.13%84.5%
Gross Profit45.31B60.33B62.77B39.65B61.04B68.49B45.22B31.95B26.34B23.77B21.31B22.59B18.67B
Gross Margin %11.86%12.8%15.06%10.9%15.9%18.89%16.73%15.62%14.5%14.57%12.51%13.87%15.5%
Gross Profit Growth %--3.9%58.32%-35.04%-10.87%51.46%41.54%21.28%10.8%11.53%-5.65%20.98%-
Operating Expenses30.62B37.7B39.01B34.35B35.75B35.14B24.77B18.5B19.18B17.04B14.73B13.47B10.48B
OpEx % of Revenue-8%9.36%9.44%9.31%9.69%9.17%9.04%10.56%10.45%8.64%8.27%8.7%
Selling, General & Admin30.33B37.78B36.99B33.98B34.95B29.77B23.99B18.49B16.38B17.11B14.4B13.4B10.48B
SG&A % of Revenue-8.02%8.87%9.34%9.1%8.21%8.88%9.04%9.01%10.49%8.45%8.23%8.7%
Research & Development0000000000000
R&D % of Revenue-------------
Other Operating Expenses-2M-78.47M2.02B368.69M798.25M5.36B778.1M5.16M2.8B-69.15M325.27M66.73M0
Operating Income14.69B22.63B23.76B5.3B25.29B33.35B20.45B13.45B7.16B6.73B6.58B9.12B8.19B
Operating Margin %3.84%4.8%5.7%1.46%6.59%9.2%7.57%6.58%3.94%4.12%3.86%5.6%6.8%
Operating Income Growth %--4.78%348.17%-79.04%-24.16%63.09%52.06%87.9%6.38%2.18%-27.8%11.37%-
EBITDA25.86B35.25B33.46B14.06B35.38B42.68B26.85B18.54B11.93B11.17B11.06B12.79B10.74B
EBITDA Margin %6.77%7.48%8.02%3.86%9.21%11.77%9.94%9.06%6.57%6.85%6.49%7.85%8.91%
EBITDA Growth %-31.02%5.37%137.94%-60.26%-17.09%58.94%44.83%55.34%6.8%1.04%-13.52%19.13%-
D&A (Non-Cash Add-back)11.16B12.63B9.69B8.76B10.09B9.33B6.4B5.09B4.78B4.45B4.48B3.67B2.55B
EBIT15.8B23.58B25.69B5.96B25.89B33.65B21.27B13.2B7.33B6.69B7.04B9.12B7.81B
Net Interest Income-5.04B-6.88B-1.19B-1.41B-1.07B-830.84M-3.77B-4.07B-3.65B-4.5B-3.32B-2.46B-2.61B
Interest Income907.36M2.3B453.73M326.44M268.42M144.33M0000000
Interest Expense5.95B9.18B1.65B1.73B1.34B975.16M3.77B4.07B3.65B4.5B3.32B2.46B2.61B
Other Income/Expense-6.92B-8.23B-8.94B-6.7B-6.5B-5.13B-12.19B-5.95B-8.26B-5.58B-6.29B-1.24B-4B
Pretax Income7.77B14.4B14.82B-1.4B18.79B28.22B8.26B7.5B-1.1B1.15B290.82M7.88B4.19B
Pretax Margin %2.03%3.06%3.55%-0.38%4.89%7.78%3.06%3.67%-0.6%0.71%0.17%4.84%3.48%
Income Tax801.49M2.17B4.12B-668.94M2.17B6.93B3.61B1.03B-1.31B126.29M-274.26M2.75B1.79B
Effective Tax Rate %10.32%15.09%27.78%47.85%11.54%24.57%43.67%13.78%119.13%10.96%-94.31%34.9%42.59%
Net Income6.41B11.1B9.62B-1.06B15.85B21.24B4.6B6.07B25.2M534.2M233.56M4.64B2.04B
Net Margin %1.68%2.36%2.31%-0.29%4.13%5.86%1.7%2.97%0.01%0.33%0.14%2.85%1.69%
Net Income Growth %-47.54%15.4%1006.33%-106.69%-25.38%361.95%-24.22%23981.78%-95.28%128.72%-94.97%127.91%-
Net Income (Continuing)6.97B12.23B10.7B-729.14M16.62B21.28B4.65B6.46B210.12M1.03B565.09M5.13B2.41B
Discontinued Operations0000000000000
Minority Interest834.76M4.51B34.57B17.93B3.46B3.68B3.42B2.85B2.3B1.85B1.14B1.59B1.77B
EPS (Diluted)6.2810.410.80-0.487.098.581.732.280.010.190.091.600.71
EPS Growth %12.34%1201.25%266.67%-106.77%-17.37%395.95%-24.12%--95%121.45%-94.64%125.35%-
EPS (Basic)-10.410.80-0.487.098.581.732.280.010.190.091.600.71
Diluted Shares Outstanding1.02B1.07B2.22B2.22B2.25B2.48B2.66B2.67B2.67B2.85B2.73B2.9B2.88B
Basic Shares Outstanding1.02B1.07B2.22B2.22B2.25B2.48B2.66B2.66B2.66B2.83B2.72B2.9B2.88B
Dividend Payout Ratio-79.38%46.14%-27.99%34.82%31.34%0.1%503.52%17.48%471.89%10.4%10.8%

Key Metrics

Growth RegimeDecelerating
ProfitabilityStrained
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

High leverage and margin compression

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-Q (2026Q2)

Revenue Momentum Fades Sharply

Revenue growth decelerated from 28.0% in 2025Q1 to -79.9% in 2026Q2, with reported revenue collapsing to $23.9B from $119.0B a year earlier, according to the latest quarterly data.

The dramatic revenue decline in 2026Q2 appears to reflect a significant change in reporting or a one-off event, as the sequential drop from $111.5B in 2026Q1 is unprecedented. This suggests that the underlying business may be facing severe demand destruction or that the company has divested major operations, though the data does not specify. Investors should monitor whether this is a structural shift or a temporary anomaly, as the prior quarters showed robust double-digit growth.

Gross Margin Erosion Accelerates

Gross margin fell from 16.5% in 2024Q3 to 10.8% in 2026Q2, a 570 basis point contraction, reflecting intense input cost pressure and limited pricing power, as reported in the income statement data.

The persistent decline in gross margin, despite revenue growth in earlier quarters, indicates that JBS is unable to pass through higher livestock and feed costs to customers. The 2026Q2 gross margin of 10.8% is below the peer average, with Tyson at 6.5% and Hormel at 15.6%, suggesting JBS is losing its cost advantage. This margin compression is likely to persist given the tight US cattle supply and record feeder cattle prices, which may continue to pressure the beef segment.

Operating Leverage Reverses

Operating income swung from $8.6B in 2024Q3 to $597M in 2026Q2, with operating margin contracting from 7.8% to 2.5%, indicating that fixed costs are no longer being absorbed by revenue growth.

The sharp decline in operating income, despite relatively stable SG&A as a percentage of revenue, suggests that the company's cost structure is not flexible enough to adapt to the revenue downturn. In 2026Q2, SG&A of $2.0B on $23.9B revenue implies an SG&A ratio of 8.4%, which is higher than the 7-8% range seen in prior quarters, indicating that overhead costs are not scaling down with revenue. This reversal of operating leverage may indicate that the company's cost base is too rigid for the current demand environment.

Earnings Quality Deteriorates

Net income turned negative at -$102.1M in 2026Q2, with EPS of -$0.09 versus an estimate of $2.13, while stock-based compensation of $101.8M adds to the earnings drag, based on the latest quarterly report.

The significant EPS miss and the negative net income in 2026Q2 raise concerns about the quality of earnings, as the company may be incurring non-operating charges or impairments that are not fully disclosed. The presence of stock-based compensation, which was zero in 2026Q1, suggests that the company may be using equity-based incentives to preserve cash, which could dilute shareholders. Investors should scrutinize the sustainability of earnings, as the current profitability appears to be below the cost of capital.

Cost Pressures Intensify

COGS as a percentage of revenue rose to 89.2% in 2026Q2 from 83.5% in 2024Q3, indicating that input costs are consuming a larger share of sales, as per the income statement data.

The rising COGS ratio highlights the company's vulnerability to commodity price fluctuations, particularly in beef and poultry feed. While SG&A has remained relatively stable in absolute terms, the increase in COGS has more than offset any operational efficiencies, leading to a gross profit decline of over 80% year-over-year in 2026Q2. This suggests that management's cost discipline is being overwhelmed by external cost pressures, and without a recovery in livestock cycles, margins may remain under pressure.

What Could Invalidate the Bull Case

The 2026Q2 revenue collapse and negative EPS suggest that the company may be facing a structural break, not just cyclical headwinds, which could challenge the narrative of a diversified global protein platform.

Short-sellers might argue that the dramatic revenue decline and margin compression indicate that JBS's multi-protein diversification is not providing the expected resilience, and that the company's high leverage (Debt/Equity of 2.40) could become a solvency risk if earnings do not recover. The absence of formal guidance and the unexplained revenue drop warrant caution, as it may signal undisclosed operational issues or accounting changes. If the company cannot restore profitability to prior levels, the stock could face further de-rating.

JBS — Frequently Asked Questions

Quick answers to the most common questions about buying JBS stock.

What was Jbs N.V.'s (JBS) revenue in 2025?

For fiscal year 2025, Jbs N.V. (JBS) reported total revenue of $471.14B. This represents a 291.1% increase compared to $120.47B in 2014.

Is Jbs N.V. (JBS) profitable?

Jbs N.V. (JBS) is profitable, generating $11.10B in net income for the fiscal year ending 2025 with a net profit margin of 2.4%.

What is Jbs N.V.'s operating profit margin?

Jbs N.V. (JBS) reported an operating income of $22.63B, resulting in an operating profit margin of 4.8%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Jbs N.V.'s gross profit and gross margin?

Jbs N.V. (JBS) generated $60.33B in gross profit for the year, representing a gross profit margin of 12.8%. This demonstrates the company's core pricing power and production efficiency.